<!DOCTYPE html>

<html lang="en">
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title></title>
	<link rel="stylesheet" href="css/hm.css" type="text/css" />
	<link rel="stylesheet" href="css/animate.css" type="text/css" />
	<script type="text/javascript" src="js/base.js"></script>
	<script type="text/javascript" src="js/Common.js"></script>
	<script type="text/javascript" charset="utf-8">
		
		var ANIMATION = [];
		
	</script>
</head>
<body class="popup-1-1">
	<div id="popup">
		<h3>Indication<sup>1</sup></h3>
	    <p>KALETRA<sup>&reg;</sup> (lopinavir/ritonavir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). The following points should be considered when initiating therapy with KALETRA:
	</p>
	    
	    <div class="blk_bullet">The use of other active agents with KALETRA is associated with a greater likelihood of treatment response.</div>
	    
	    <div class="blk_bullet">Genotypic or phenotypic testing and/or treatment history should guide the use of KALETRA. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to KALETRA.</div>
    
    </div>

</body>
</html>